D e s i g n
Randomized (allocation concealed*), unblinded,* controlled trial with mean follow-up of 3.2 years (the Finnish Diabetes Prevention Study).
S e t t i n g
5 locations in Finland (Helsinki, Kuopio, Oulu, Tampere, and Turku).
P a t i e n t s
522 patients between 40 and 65 years of age (mean age 55 y, 67% women) who were overweight (body mass index ≥ 25 kg/m 2 ) and had impaired glucose tolerance (mean plasma glucose level between 7.8 and 11.0 mmol/L 2 h after receiving 75 g of oral glucose on 2 occasions, in patients with plasma glucose levels < 7.8 mmol/L after an overnight fast). Exclusion criteria included diabetes mellitus and advanced chronic disease. Follow-up was 92%.
I n t e r v e n t i o n
Patients were allocated to receive individualized counseling aimed at reducing weight by ≥ 5%, reducing total and saturated fat intake, increasing intake of fiber, and increasing physical activity to at least 30 min/d (intervention group, n = 265) or general oral and written information about diet and exercise (control group, n = 257).
M a i n o u t c o m e m e a s u r e s
The primary outcome measure was incidence of newly diagnosed type 2 diabetes (confirmed by 2 oral glucose tolerance tests). A secondary outcome measure was amount of weight loss.
M a i n r e s u l t s
Analysis was by intention to treat. At 2 years, persons in the intervention group had a greater mean weight loss than did those in the control group (3.5 vs 0.8 kg, P < 0.001). At 4 years, the incidence of diabetes was lower in the intervention group than in the control group (P < 0.001) (Table) .
C o n c l u s i o n
An individualized lifestyle-intervention program aimed at improving dietary habits and increasing physical activity was effective for preventing type 2 diabetes mellitus in persons with impaired glucose tolerance. 
C o m m e n t a r y
Persons who have a family history of type 2 diabetes, gestational diabetes, or signs of metabolic syndrome (i.e., abdominal obesity, hypertriglyceridemia, or impaired fasting glucose) are at high risk for developing type 2 diabetes (1). A 6-year randomized trial done in China (2) suggests that diet and exercise may decrease the risk for diabetes in these patients. In practice, some patients do not start or sustain these nonpharmacologic interventions, and clinicians are usually skeptical about the efficacy of lifestyle-modification interventions. Consequently, researchers are also evaluating medications (e.g., acarbose, metformin, and angiotensin-converting enzyme inhibitors) that may prevent or delay the development of diabetes. The study by Tuomilehto and colleagues offers evidence for the sustained effectiveness of an intensive dietary and exercise intervention in patients with impaired glucose tolerance. This evidence is weakened by the lack of blinding of investigators. Furthermore, the intervention may not be as effective in usual practice because of differences that may exist between the volunteer participants and usual patients and because of the inability of usual-practice systems to provide intensive and individualized dietary and exercise interventions.
Nevertheless, clinicians should not be overly skeptical about their ability to modify a patient's lifestyle. This study suggests that such goals may not need to be ambitious to be effective. Patients who are at high risk for diabetes may benefit from intensive and individualized diet, and at-risk patients should collaborate with their physicians in establishing exercise programs.
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